UPM Institutional Repository

Liver antifibrosis mechanisms of oligomeric grape seed proanthocyanidins 40%: role of collagen and MMP-1 modulation


Citation

Widyawati, Ratna and Widyarini, Sitarina and Kadir, Arifah Abdul and Yuniarti, Wiwik Misaco and Lukiswanto, Bambang Sektiari and Astuti, Pudji and Airin, Claude Mona and Sarmin, Sarmin (2026) Liver antifibrosis mechanisms of oligomeric grape seed proanthocyanidins 40%: role of collagen and MMP-1 modulation. Inflammopharmacology, 34 (5). pp. 3615-3624. ISSN 0925-4692; eISSN: 1568-5608 (In Press)

Abstract

Bile duct ligation (BDL) induces liver fibrosis, representing a significant clinical challenge. Oligomeric grape seed proanthocyanidins (O-GSPE) 40% have demonstrated potential therapeutic benefits in various inflammatory conditions. This study aimed to elucidate the mechanisms underlying the hepatoprotective and anti-inflammatory effects of O-GSPE 40% in a rat model of BDL, focusing on the role of collagen and matrix metalloproteinase-1 (MMP-1). Eighteen male Wistar rats were subjected to BDL, divided into three groups of 6. Group I: negative control (sham surgery), Group II: positive control (surgery with BDL), and Group III: BDL+ treated with O-GSPE 40% for 21 days. The liver was removed and stained with Masson-Trichrome and antibodies against collagen and MMP-1. Collagen density and the expression of collagen and MMP-1 were observed using a light microscope. Histopathological findings demonstrate that BDL significantly increased collagen density and the expression of collagen and MMP-1 in the liver, consistent with the development of fibrosis. Treatment with O-GSPE at 40% reduced collagen density and the expression of collagen and MMP-1 in the liver, although the differences were not statistically significant, indicating a protective effect against liver fibrosis. O-GSPE 40% demonstrates hepatoprotective effects in BDL-induced liver injury. These beneficial effects are associated with the role of collagen and MMP-1. These findings suggest that O-GSPE 40% may represent a promising therapeutic agent for managing liver fibrosis.


Download File

[img] Text
124625.pdf - Published Version
Restricted to Repository staff only

Download (11MB)

Additional Metadata

Item Type: Article
Subject: Immunology
Subject: Pharmacology
Subject: Pharmacology (medical)
Divisions: Faculty of Veterinary Medicine
DOI Number: https://doi.org/10.1007/s10787-026-02202-9
Publisher: Springer Science and Business Media Deutschland
Keywords: Bdl; Collagen; Liver fibrosis; Mmp-1; O-gspe
Sustainable Development Goals (SDGs): SDG 3: Good Health and Well-being, SDG 12: Responsible Consumption and Production, SDG 15: Life on Land
Depositing User: Ms. Siti Radziah Mohamed@mahmod
Date Deposited: 24 Jun 2026 02:44
Last Modified: 24 Jun 2026 02:44
Altmetrics: https://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1007/s10787-026-02202-9
URI: http://psasir.upm.edu.my/id/eprint/124625
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item